MRI scans, magnesium diboride

March 26, 2014 -- Based on its recent analysis of the superconductor technology for MRI market, Frost & Sullivan recognizes Cutting Edge Superconductors, Inc. with the 2013 North American Frost & Sullivan Award for Technology Innovation Leadership. CES, Inc. developed a proprietary technology based on magnesium diboride superconducting wire, which enabled cryogen-free 1.5T and 3.0T magnetic resonance imaging (MRI) with image qualities similar to the currently available 1.5T MRI. The technology leveraged innovative customizations in the chemistry of the material by adding both magnetic and non-magnetic impurities to magnesium diboride wires. This resulted in improvements to the critical currents of superconducting magnesium diboride wires.
 
The cryogen-free 0.5T MRI delivers images of average quality when compared to 1.5T MRI, as the quality of image is directly dependent on the square of the strength of the magnetic field. However, the current 1.5T MRI technology requires the use of cost-intensive liquid helium, which increases the cost of maintenance and operation, as well as initial cost.
 
"The next-generation, cryogen-free 1.5T and 3.0T MRI technology promises a reduction in the MRI scan cost by up to 40 percent due to the financial viability and simplicity of the MRI equipment," said Frost & Sullivan Senior Research Analyst Avimanu Basu. "This cost-effectiveness is achieved by maintaining a higher operating temperature of 20 degrees K with the help of a cryocooler, which eliminates the need for expensive liquid helium."
 
Furthermore, the technology is maintenance-free and extends the equipment's longevity to 10 to 20 years. The presently available MRI has a lifetime of five to seven years and is complex and expensive to maintain, as it employs superconducting NbTi wires that operate at a temperature of 4 degrees K. This necessitates cooling with the help of 1,700 liters of liquid helium cryogen.
 
"CES, Inc.'s technology is aimed at improving the current-carrying capacity of wires and thus, the field strength of the magnet," noted Basu. "On the one hand, this makes the device more industrially viable and simple and on the other, it supports the development of a range of applications across industries."
 
The technology is expected to influence a wide spectrum of industries such as electrical power (generation, transmission, and distribution), healthcare, air travel and defense. It can also be applied in high-performance cryogen-free magnets for scientific nuclear magnetic resonance (NMR), accelerators and fusion reactors. In addition, it can benefit small hospitals in economically unstable nations in the form of low-cost, high-quality portable MRI.
 
Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing a technology, which significantly impacts both the functionality and the customer value of new products and applications. The award lauds the relevance of the innovation to the industry.
 

Related Content

News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Subscribe Now